HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Curcumin sulfate

HCID 66645351
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
339286-19-0
Standard SMILES
COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(OC)c2)ccc1O
InChIKey
NEJVQQBBTRFOHB-FCXRPNKRSA-N
Molecular formula
C21H20O9S
Average molar mass
448.4 g/mol
Monoisotopic mass
448.08280338

Overview

Curcumin sulfate is a diarylheptanoid.

Names & identifiers

Preferred name
Curcumin sulfate
IUPAC
[4-[(1E,6E)-7-(4-hydroxy-3-methoxyphenyl)-3,5-dioxohepta-1,6-dienyl]-2-methoxyphenyl] hydrogen sulfate
English name
Curcumin Sulfate Sodium Salt
Molecular formula
C21H20O9S
Molecular weight
448.44

Names & synonyms

Curcumin sulfateCurcumin sulphate339286-19-0Curcumin monosulfateUNII-160DHE331M160DHE331M1,6-Heptadiene-3,5-dione, 1-(4-hydroxy-3-methoxyphenyl)-7-(3-methoxy-4-(sulfooxy)phenyl)-, (1E,6E)-4-((1E,4Z,6E)-5-Hydroxy-7-(4-hydroxy-3-methoxyphenyl)-3-oxohepta-1,4,6-trien-1-yl)-2-methoxyphenyl hydrogen sulfateDTXSID10893526{4-[(1E,6E)-7-(4-hydroxy-3-methoxyphenyl)-3,5-dioxohepta-1,6-dien-1-yl]-2-methoxyphenyl}oxidanesulfonic acid(4-((1E,6E)-7-(4-hydroxy-3-methoxyphenyl)-3,5-dioxohepta-1,6-dien-1-yl)-2-methoxyphenyl)oxidanesulfonic acidRefChem:128879
Show more names
Curcumin Sulfate-d6Curcumin sulfate triethylamineCurcumin-O-Sulfate DISCONTINUED, offer C838520Curcumin monosulfate/Curcumin sulfate/Curcumin Sulfate Tetrabutylammonium Salt1,6-Heptadiene-3,5-dione, 1-(4-hydroxy-3-methoxyphenyl)-7-[3-methoxy-4-(sulfooxy)phenyl]-, (1E,6E)-Curcumin Sulfate Sodium saltQ: What is Curcumin Sulfate Sodium salt Q: What is the CAS Number of Curcumin Sulfate Sodium salt Q: What is the storage condition of Curcumin Sulfate Sodium salt Q: What are the applications of Curcumin Sulfate Sodium salt

Properties

Computed structural propertiesFilling in

XLogP
2.6
Topological polar surface area
145 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
9
Rotatable bonds
10
Heavy atoms
31
Formal charge
0
Complexity
768

Physicochemical properties

solubility
DMSO (Slightly), Methanol (Sparingly)
form
Solid
color
Yellow to Dark Yellow
Stability
Hygroscopic
FDA UNII
160 DHE331M · 160DHE331M

Chemistry & industry

Pharmacology

Protein BindingNo pharmacokinetic data available.
Pharmacodynamics · 1 item

Intravenous application of 25 mg/kg bw curcumin to rats resulted in an increase in bile flow by 80 and 120%. In the rat model of inflammation, curcumin was shown to inhibit edema formation. In nude mouse that had been injected subcutaneously with prostate cancer cells, administration of curcumin caused a marked decrease in the extent of cell proliferation, a significant increase of apoptosis and micro-vessel density. Curcumin may exert choleretic effects by increasing biliary excretion of bile salts, cholesterol, and bilirubin, as well as increasing bile solubility. Curcumin inhibited arachidonic acid-induced platelet aggregation _in vitro_.

Mechanism of Action · 1 item

Curcumin acts as a scavenger of oxygen species, such as hydroxyl radical, superoxide anion, and singlet oxygen and inhibit lipid peroxidation as well as peroxide-induced DNA damage. Curcumin mediates potent anti-inflammatory agent and anti-carcinogenic actions via modulating various signalling molecules. It suppresses a number of key elements in cellular signal transduction pathways pertinent to growth, differentiation, and malignant transformation; it was demonstrated _in vitro_ that curcumin inhibits protein kinases, c-Jun/AP-1 activation, prostaglandin biosynthesis, and the activity and expression of the enzyme cyclooxygenase (COX)-2.

Biological Half-LifeNo pharmacokinetic data available.
Metabolism/Metabolites · 1 item

Initially, curcumin undergoes rapid intestinal metabolism to form curcumin glucuronide and curcumin sulfate via O-conjugation. Other metabolites formed include tetrahydrocurcumin, hexahydrocurcumin, and hexahydrocurcuminol via reduction. Curcumin may also undergo intensive second metabolism in the liver where the major metabolites were glucuronides of tetrahydrocurcumin and hexahydrocurcumin, with dihydroferulic acid and traces of ferulic acid as further metabolites. Hepatic metabolites are expected to be excreted in the bile. Certain curcumin metabolites, such as tetrahydrocurcumin, retain anti-inflammatory and antioxidant properties.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
DTXCID001323548NOCAS_8935264-((1E,6E)-7-(4-Hydroxy-3-methoxyphenyl)-3,5-dioxohepta-1,6-dien-1-yl)-2-methoxyphenyl hydrogen sulfateCurcumin Sulfate Sodium Salt[4-[(1E,6E)-7-(4-hydroxy-3-methoxyphenyl)-3,5-dioxohepta-1,6-dienyl]-2-methoxyphenyl] hydrogen sulfate4-[(1E,6E)-7-(4-Hydroxy-3-methoxyphenyl)-3,5-dioxohepta-1,6-dien-1-yl]-2-methoxyphenyl hydrogen sulfateCurcumin Impurity 12SCHEMBL290796

Database identifiers

CAS
339286-19-0
PubChem CID
66645351
DTXSID
DTXSID10893526
ChEBI
CHEBI:189746
UNII
160DHE331M
Nikkaji
J3.281.992C
Absorption, Distribution and Excretion · 4 items

Curcumin displays poor absorption into the gastrointestinal tract. In a rat study, oral administration of a single dose of 2 g of curcumin resulted in a plasma concentration of less than 5 μg/mL, indicating poor absorption from the gut.

Following oral administration of curcumin to rats at a dose of 1 g/kg bw, about 75% of dose was excreted in the faeces and only traces of the compound was detected in the urine. When a single 400 mg dose of curcumin was administered orally to rats, about 60% was absorbed and 40% was excreted unchanged in the faeces over an period of 5 days. Intraperitoneal administration resulted in fecal excretion of 73% and biliary excretion of 11%.

Following oral administration of radio-labelled curcumin to rats, radioactivity was detected in the liver and kidneys.

No pharmacokinetic data available.

Applications

UsesCurcumin Sulfate is a metabolite of Curcumin (C838510) in hepatic tissue and portal blood.

Additional notes

DefinitionChEBI: Curcumin sulfate is a diarylheptanoid.